Chemokines

ALX 40-4C Trifluoroacetate is a small peptide inhibitor of the chemokine receptor CXCR4, inhibits SDF-1 from binding CXCR4 with a Ki of 1 μM, and suppresses the replication of X4 strains of HIV-1 ALX 40-4C Trifluoroacetate also acts as an

ALX 40-4C Trifluoroacetate is a small peptide inhibitor of the chemokine receptor CXCR4, inhibits SDF-1 from binding CXCR4 with a Ki of 1 μM, and suppresses the replication of X4 strains of HIV-1 ALX 40-4C Trifluoroacetate also acts as an

ALX 40-4C Trifluoroacetate is a small peptide inhibitor of the chemokine receptor CXCR4, inhibits SDF-1 from binding CXCR4 with a Ki of 1 μM, and suppresses the replication of X4 strains of HIV-1 ALX 40-4C Trifluoroacetate also acts as an

AMG 487 S-enantiomer is the S enantiomer of AMG 487. AMG 487 is an antagonist of the chemokine receptor CXCR3 .In VitroAMG 487 S-enantiomer (Compound 3.74) is the S enantiomer of AMG 487. MCE has not independently confirmed the accuracy of these

AMG 487 S-enantiomer is the S enantiomer of AMG 487. AMG 487 is an antagonist of the chemokine receptor CXCR3 .In VitroAMG 487 S-enantiomer (Compound 3.74) is the S enantiomer of AMG 487. MCE has not independently confirmed the accuracy of these

AZD8309 is an orally active antagonist of CXCR2 . AZD8309 has the ability to regulate the transmigration of neutrophils. AZD8309 can be used in the study of inflammatory diseasesIn VivoAZD8309 (50 mg/kg p.o. twice daily) reduces neutrophil

AZD8309 is an orally active antagonist of CXCR2 . AZD8309 has the ability to regulate the transmigration of neutrophils. AZD8309 can be used in the study of inflammatory diseasesIn VivoAZD8309 (50 mg/kg p.o. twice daily) reduces neutrophil

AZD8797 (KAND567) is an allosteric non-competitive and orally active antagonist of the human CX3CR1 receptor antagonizes CX3CR1 and CXCR2 with K i s of 3.9 and 2800 nM, respectively.In VitroIn a flow adhesion assay, AZD8797 antagonizes the natural

AZD8797 (KAND567) is an allosteric non-competitive and orally active antagonist of the human CX3CR1 receptor antagonizes CX3CR1 and CXCR2 with K i s of 3.9 and 2800 nM, respectively.In VitroIn a flow adhesion assay, AZD8797 antagonizes the natural

AZD8797 (KAND567) is an allosteric non-competitive and orally active antagonist of the human CX3CR1 receptor antagonizes CX3CR1 and CXCR2 with K i s of 3.9 and 2800 nM, respectively.In VitroIn a flow adhesion assay, AZD8797 antagonizes the natural

AZD8797 (KAND567) is an allosteric non-competitive and orally active antagonist of the human CX3CR1 receptor antagonizes CX3CR1 and CXCR2 with K i s of 3.9 and 2800 nM, respectively.In VitroIn a flow adhesion assay, AZD8797 antagonizes the natural

AZD8797 (KAND567) is an allosteric non-competitive and orally active antagonist of the human CX3CR1 receptor antagonizes CX3CR1 and CXCR2 with K i s of 3.9 and 2800 nM, respectively.In VitroIn a flow adhesion assay, AZD8797 antagonizes the natural